SEC reporting owner

VIVO VENTURES VII, LLC SEC insider disclosures

Explore VIVO VENTURES VII, LLC's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001565020
Issuers
5
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

MEI Pharma, Inc.0001262104MEIPNoNo
CODEXIS INC0001200375CDXSNoNo
Sierra Oncology, Inc.0001290149DNAI, SRRANoYes
Aclaris Therapeutics, Inc.0001557746ACRSNoNo
AIRXPANDERS INC0001387156AXPNoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.